Market Vulnerabilities and Corporate Outlooks Amid Shifting Consumer Trends

This chapter examines recent quarterly results from key companies, focusing on shifts towards private label products and Biogen's forecasts for its multiple sclerosis franchise. It also addresses concerns from a hedge fund CEO about U.S. trade policies and provides analyst insights on potential vulnerabilities within the 'magnificent seven' tech stocks.